This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Aurigene Oncology Limited, Olema Pharmaceuticals, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Raymond A Ng
Introduction
Raymond A Ng is a notable inventor based in Pleasant Hill, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways. His work is characterized by a focus on therapeutic applications that can address critical health issues.
Latest Patents
One of Raymond A Ng's key patents is for acylsulfonamide KAT6A inhibitors. This patent describes acylsulfonamide compounds of Formula (J), along with their pharmaceutically acceptable salts, compositions, methods, and uses. These compounds are believed to be therapeutically useful as KAT6A inhibitors, particularly in the treatment and prevention of diseases and disorders mediated by KAT6A in a subject. This innovation highlights his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout his career, Raymond A Ng has worked with several prominent companies in the pharmaceutical industry. Notably, he has been associated with Olema Pharmaceuticals, Inc. and Aurigene Oncology Limited. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Raymond has collaborated with notable professionals such as Brian R Hearn and David C Myles. These partnerships have enriched his work and facilitated the exchange of ideas that drive innovation in the pharmaceutical sector.
Conclusion
Raymond A Ng's contributions to the field of pharmaceuticals, particularly through his patent on acylsulfonamide KAT6A inhibitors, demonstrate his dedication to advancing medical research. His collaborations and career experiences further underscore his impact on the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile